In a different study, the number of EVs significantly increased in breast cancer cells exposed to paclitaxel and doxorubicin and also became enriched with the cell signaling protein annexin 6 (ANXA6) that enhanced premetastatic capacity in vitro. Here, ANXA6 is linked to breast carcinoma.